Gada, Hemal

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Kleiman, Neal S; Van Mieghem, Nicolas M; Reardon, Michael J; Gada, Hemal; Mumtaz, Mubashir; Olsen, Peter Skov; Heiser, John; Merhi, William; Chetcuti, Stanley; Deeb, G Michael; Chawla, Atul; Kiaii, Bob; Teefy, Patrick; Chu, Michael W A; Yakubov, Steven J; Windecker, Stephan; Althouse, Andrew D; Baron, Suzanne J (2024). Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients. JACC. Cardiovascular Interventions, 17(8), pp. 979-988. Elsevier 10.1016/j.jcin.2024.02.014

van Bergeijk, Kees H; Wykrzykowska, Joanna J; van Mieghem, Nicolas M; Windecker, Stephan; Sondergaard, Lars; Gada, Hemal; Li, Shuzhen; Hanson, Tim; Deeb, G Michael; Voors, Adriaan A; Reardon, Michael J (2023). Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial). The American journal of cardiology, 200, pp. 78-86. Elsevier 10.1016/j.amjcard.2023.05.036

Van Mieghem, Nicolas M; Deeb, G Michael; Søndergaard, Lars; Grube, Eberhard; Windecker, Stephan; Gada, Hemal; Mumtaz, Mubashir; Olsen, Peter S; Heiser, John C; Merhi, William; Kleiman, Neal S; Chetcuti, Stanley J; Gleason, Thomas G; Lee, Joon Sup; Cheng, Wen; Makkar, Raj R; Crestanello, Juan; George, Barry; George, Isaac; Kodali, Susheel; ... (2022). Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA cardiology, 7(10), pp. 1000-1008. American Medical Association 10.1001/jamacardio.2022.2695

Yakubov, Steven J; Van Mieghem, Nicolas M; Reardon, Michael J; Serruys, Patrick W; Gada, Hemal; Mumtaz, Mubashir; Deeb, G Michael; Kodali, Susheel; George, Isaac; Windecker, Stephan; Kleiman, Neal; Chetcuti, Stanley J; Sanchez, Carlos; Dauerman, Harold L; Li, Shuzhen; Popma, Jeffrey J (2020). Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). The American journal of cardiology, 131, pp. 82-90. Elsevier 10.1016/j.amjcard.2020.06.051

Van Mieghem, Nicolas M; Popma, Jeffrey J; Deeb, G Michael; Yakubov, Steven J; Serruys, Patrick W; Windecker, Stephan; Søndergaard, Lars; Mumtaz, Mubashir; Gada, Hemal; Chetcuti, Stanley; Kleiman, Neal S; Kodali, Susheel; George, Isaac; Teefy, Patrick; Kiaii, Bob; Oh, Jae K; Kappetein, Arie Pieter; Chang, Yanping; Mugglin, Andrew S and Reardon, Michael J (2020). Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC. Cardiovascular Interventions, 13(3), pp. 323-331. Elsevier 10.1016/j.jcin.2019.10.043

Reardon, Michael J; Van Mieghem, Nicolas M; Popma, Jeffrey J; Kleiman, Neal S; Søndergaard, Lars; Mumtaz, Mubashir; Adams, David H; Deeb, G Michael; Maini, Brijeshwar; Gada, Hemal; Chetcuti, Stanley; Gleason, Thomas; Heiser, John; Lange, Rüdiger; Merhi, William; Oh, Jae K; Olsen, Peter S; Piazza, Nicolo; Williams, Mathew; Windecker, Stephan; ... (2017). Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. New England journal of medicine NEJM, 376(14), pp. 1321-1331. Massachusetts Medical Society MMS 10.1056/NEJMoa1700456

This list was generated on Thu Nov 21 12:55:09 2024 CET.
Provide Feedback